Christie Ann Kelton

Title: Christie Ann Kelton: Innovator in Hybrid Antigen Binding Molecules

Introduction

Christie Ann Kelton is a notable inventor based in Hopkinton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of hybrid antigen binding molecules. With a total of 8 patents to her name, her work has implications for both diagnosis and therapy in medical applications.

Latest Patents

One of her latest patents focuses on "Compositions and methods of producing hybrid antigen binding molecules and uses thereof." This disclosure relates to hybrid antigen binding molecules that include at least two polypeptide chains, with at least one chain comprising an antigen binding moiety linked to an amino acid sequence of a subunit of a heterodimeric proteinaceous hormone. The patent also outlines methods for making and using these hybrid molecules for diagnostic and therapeutic purposes. Another significant patent involves "Methods for assaying human FSH using human FSH receptor." This invention includes essentially pure human FSH receptor, or a fragment or mutant that binds FSH, along with DNA encoding said receptor and methods for producing it.

Career Highlights

Christie has worked with prominent companies in the biotechnology sector, including Genzyme Corporation and Applied Research Systems. Her experience in these organizations has contributed to her expertise in the field and her ability to innovate.

Collaborations

Throughout her career, Christie has collaborated with notable colleagues such as Noreen P Nugent and Rene Lynn Schweickhardt. These collaborations have likely enriched her work and expanded her impact in the industry.

Conclusion

Christie Ann Kelton's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical diagnostics and therapies.